Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: Role of adenosine and proinflammatory cytokines

Rheumatology

Volumn 41, Issue 11, 2002, Pages 1249-1260

  Ottonello, L ^a   Cutolo, M ^a   Frumento, G ^b   Arduino, N ^a   Bertolotto, M ^a   Mancini, M ^a   Sottofattori, E ^a   Dallegri, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Adenosine; Apoptosis; GM CSF; Neurophils; Rheumatoid arthritis; TNF

Indexed keywords

ADENOSINE; AURANOFIN; CORTICOSTEROID; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; LEFLUNOMIDE; LIPOCORTIN 5; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; JOINT EFFUSION; KNEE ARTHRITIS; LEUKOCYTE ACTIVATION; MALE; MICROENVIRONMENT; MICROSCOPY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADENOSINE; ADULT; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-8; KNEE JOINT; MALE; MIDDLE AGED; NEUTROPHILS; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036852272     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Harris DE. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Mohr W, Westerhellweg H, Wessinghage D. Polymorphonuclear granulocytes in rheumatic tissue destruction. III. An electron microscopic study of PMNs at pannus-cartilage junction in rheumatoid arthritis. Ann Rheum Dis 1981;40:396-9.
3. Bromley M, Woolley DE. Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984;27:857-63.
4. Menninger H, Putzier R, Mohr W, Wessinghage D, Tillmann K. Granulocyte elastase at the site of cartilage erosion by rheumatoid synovial tissue. Z Rheumatol 1980;39:145-56.
5. Chatham WW, Swaim R, Frohsin H Jr, Heck LW, Miller EJ, Blackburn WD Jr. Degradation of human articular cartilage by neutrophils in synovial fluid. Arthritis Rheum 1993;36:51-8.
6. Deleuran BW. Cytokines in rheumatoid arthritis. Localization in arthritic joint tissue and regulation in vitro. Scand J Rheumatol 1996;25(Suppl. 104):9-13.
7. Edwards SW, Hallett MB. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997;18:320-4.
8. Ugai K, Ishikawa H, Hirohata K, Shirane H. Interaction of polymorphonuclear leukocytes with immune complexes trapped in rheumatoid articular cartilage. Arthritis Rheum 1983;26:1434-41.
9. Willis HE, Browder B, Feister AJ, Mohanakumar T, Ruddy S. Monoclonal antibody to human IgG Fc receptors. Cross-linking of receptors induces lysosomal enzyme release and superoxide generation by neutrophils. J Immunol 1988;140:234-9.
10. Ossanna PJ, Test ST, Matheson NR, Regiani S, Weiss SJ. Oxidative regulation of neutrophil elastase-alpha-1-protease inhibitor interaction. J Clin Invest 1986;77:1939-51.
11. Abbink JJ, Kamp AM, Nuijens JH, Swaak TJG, Hack CE. Proteolytic inactivation of α1-antitrypsin and chymotrypsin by neutrophils in arthritic joints. Arthritis Rheum 1993;36:168-80.
12. Henson PM, Johnston RB. Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J Clin Invest 1988;79:669-74.
13. Weiss J. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
14. Gamberale R, Giordano M, Trevani AS, Andonegui G, Geffner JR. Modulation of human neutrophil apoptosis by immune complexes. J Immunol 1998;161:3666-74.
15. Ottonello L, Frumento G, Arduino N, Dapino P, Tortolina G, Dallegri F. Immune complex stimulation of neutrophil apoptosis: investigating the involvement of oxidative and nonoxidative pathways. Free Rad Biol Med 2001;30:161-9.
16. Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 1992;83:639-48.
17. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998;101:890-8.
18. 2 integrins. J Immunol 2001;166:4743-50.
19. Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-8.
20. Xu WD, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ. Cytokines in chronic inflammatory arthritis. II. Granulocyte macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 1989; 83:876-82.
21. Alvaro-Gracia JM, Zvaifler NJ, Brown CB, Kaushansky K, Firestein GS. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha. J Immunol 1991;146:3365-71.
22. McInnes IB, al-Mughales J, Field M et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996;2:175-82.
23. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Lowry OH, Rosenbrough NH, Farr AL, Randall JR. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
25. Dankberg F, Perdisky MD. A test of granulocyte membrane integrity and phagocytic function. Cryobiology 1976; 13:430-2.
26. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-75.
27. Babior BM, Knipes RS, Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973; 52:741-50.
28. Ottonello L, Tortolina G, Amelotti M, Dallegri F. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J Immunol 1999; 162:3601-6.
29. Sottofattori E, Anzaldi M, Ottonello L. HPLC determination of adenosine in human synovial fluid. J Pharm Biomed Anal 2001;24:1143-6.
30. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80:2012-20.
31. Murray J, Barbara JAJ, Dunkley SA et al. Regulation of neutrophil apoptosis by tumor necrosis factor-α: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 1997;90:2772-83.
32. Keel M, Ungerthum U, Steckholzer U et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997;90:3356-63.
33. van den Berg JM, Weyer S, Weening JJ, Roos D, Kuijpers TW. Divergent effects of tumor necrosis factor α on apoptosis of human neutrophils. J Leukoc Biol 2001; 69:467-73.
34. Salamone G, Giordano M, Trevani AS et al. Promotion of neutrophil apoptosis by TNF-α. J Immunol 2001; 166:3479-83.
35. 2a receptor activation delays apoptosis in human neutrophils. J Immunol 1997;158:2926-31.
36. 2A receptor antagonism. J Leukoc Biol 2000;67:529-35.
37. Kammer GM. Adenosine: emerging role as an immunomodifying agent. J Lab Clin Med 1987;110:255-6.
38. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 1983; 158:1160-77.
39. Bell AL, Magill MK, McKane R, Irvine AE. Human blood and synovial fluid neutrophils cultured in vitro undergo programmed cell death which is promoted by addition of synovial fluid. Ann Rheum Dis 1995; 54:910-5.
40. Matute-Bello G, Liles WC, Radella II F et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 156:1969-71.
41. Keel M, Ungenthüm U, Steckholzer U et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997;90:3356-63.
42. Fanning NF, Kell MR, Shorten GD et al. Circulating granulocyte macrophage' colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock 1999;11:167-74.
43. Brannigan AE, O'Connell PR, Hurley H et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 2000;13:361-6.
44. Hirschhorn RV, Roegner-Maniscalco L, Kuritsky L, Rosen F. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase deficient patients. J Clin Invest 1981; 68:1387-93.
45. Saito H, Nishimura M, Shinano H et al. Plasma concentration of adenosine during normoxia and moderate hypoxia in humans. Am J Respir Crit Care Med 1999;159:1014-8.
46. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 1989; 256:C799-806.
47. Snoeck E, Ver Donck K, Jacqmin P et al. Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine. J Pharmacol Exp Ther 1998;286:142-9.
48. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993;148:91-7.
49. Driver AG, Kukoly CA, Spence PA, Chitwood WR Jr, Mustafa SJ. Pericardial fluid adenosine in ischemic and valvular heart disease. Chest 1995;107:346-51.
50. -) release by activated human neutrophils. Clin Immunol Immunopathol 1987;42:76-85.
51. Lopez S, Halbwachs-Mecarelli L, Ravaud P, Bessou G, Dougados M, Porteu F. Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis. Clin Exp Immunol 1995;101:25-32.
52. Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996; 39:1951-60.
53. Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991;88:2441-5.
54. Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate: increased release at inflamed sites diminished leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993; 92:2675-82.
55. Kraan MC, de Koster BM, Elferink JGR, Post WY, Breedveld FC, Tak PP. Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1488-95.
56. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis. Viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001; 44:493-507.
57. Cronstein BN, Montesinos MC, Weissmann G. Salicylate and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci USA 1999;96:6377-81.
58. Gasic S, Tian B, Green A. Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J Biol Chem 1992;74:6770-5.
59. Thiel M, Chouker A. Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes. J Lab Clin Med 1995;126:275-82.
60. Thatte U, Dahanukar S. Apoptosis. Clinical relevance and pharmacological manipulation. Drugs 1997;54:511-32.
61. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160:S5-11.
62. Ward C, Dransfield I, Chilvers ER, Haslett C, Rossi AG. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol Sci 1999;20:503-9.